Bank of New Hampshire Cuts Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Bank of New Hampshire trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,050 shares of the company’s stock after selling 425 shares during the quarter. Bank of New Hampshire’s holdings in Cardinal Health were worth $3,313,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CAH. Cyrus J. Lawrence LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $26,000. Promus Capital LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $30,000. Bellwether Advisors LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $32,000. Tompkins Financial Corp increased its holdings in shares of Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after purchasing an additional 128 shares in the last quarter. Finally, Lee Danner & Bass Inc. purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $35,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.4%

Shares of CAH opened at $154.68 on Friday. The firm’s fifty day moving average is $143.52 and its two-hundred day moving average is $131.51. The stock has a market cap of $36.92 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $157.82.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.15 by $0.20. The firm had revenue of $54.88 billion for the quarter, compared to analysts’ expectations of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company’s revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. Cardinal Health’s payout ratio is presently 31.83%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CAH shares. Bank of America lifted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the company a “buy” rating in a report on Friday, April 11th. Mizuho lifted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Monday, March 31st. Wells Fargo & Company raised shares of Cardinal Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $136.00 to $179.00 in a report on Tuesday, June 3rd. Citigroup reissued a “neutral” rating on shares of Cardinal Health in a report on Thursday, May 1st. Finally, UBS Group boosted their price target on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Tuesday, April 29th. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $149.50.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.